Table 1

Demographics of 103 patients with diffuse large B-cell lymphoma (DLBCL)

n%Low to moderateStrongp Value
Sex
 Male5553.4
 Female4846.6
Lymphoma subtype
 DLBCL8885.4
 T-cell-rich B-cell lymphoma1413.6
 Primary mediastinal B-cell lymphoma11.0%
B-symptoms
 None5755.32829
 Yes4341.7835
 Missing32.90.002*
Age
 <60 years3635.01521
 >60 years6765.021460.386*
LD levels
 Normal4240.81824
 Elevated6058.31743
 Missing11.00.143*
Stage
 I–II4745.61730
 III–IV5654.419370.838*
WHO performance status
 0–18077.73050
 >12120.4516
 Missing21.90.308*
Extranodal effusion
 None7669.12646
 ≥13430.910210.823*
IPI
 1–25856.32137
 3–54139.81427
 Missing43.91.000*
  • Median age was 68.00 years, range 21−90. Known risk markers of DLBCL are compared with expression of cytoplasmic peroxiredoxin VI.

  • *Fisher's exact test.

  • IPI, International Prognostic Index; LD, lactate dehydrogenase.